Erowid References Database
“Are psychedelic drug treatments seeing a comeback in psychiatry?”.
Progress in Neurology and Psychiatry. 2008 Oct 21;p5-10.
After a hiatus of nearly 40 years, psychedelic drugs (or hallucinogens) are being increasingly researched as possible adjuncts to psychotherapy for treatment-resistant anxiety disorders and addictions.This research offers an exciting future for this class of drugs whose image has been tarnished by recreational use since the 1960s.Through cautious and evidence-based studies, these medications could be finding their way back to where they began their lives: as valid and effective tools for clinical medicine and neuroscientific research.
[ Cite HTML